Focus on Aesthetic Medicine! Shiseido recruits Chinese startups
- Chaileedo Press
- Sep 16, 2022
- 2 min read
On September 15, Shiseido China announced that "Fibona", an open innovation project of Shiseido R&D Center, has recently landed in China.
CHAILEEDO learned that Shiseido set two themes of "Medical Beauty" and "Holistic Beauty" for this event. And together with Plug and Play China launched the recruitment of startups in China. It is reported that Plug and Play China is a global technology innovation platform leader.
It is worth noting that several selected startups will enter the 100-day challenge period from September for project feasibility verification and enter the final evaluation in December.
In April 2019, the Shiseido Global Innovation Center in Yokohama, Japan, began operations, and the open innovation program "Fibona" was born in this context. This program aims to create new value by merging innovative ideas and technologies from outside with Shiseido's expertise in the fields of aesthetics and science.
The "Startup Co-creation Program" is an important part of the Fibona program's activities. On the one hand, startups have innovative ideas and technologies. On the other hand, Shiseido has its strengths in products, technologies, and services. The "Startup Co-creation Program" aims to combine the two strengths in order to respond more quickly to consumer needs and market trends, and also to provide consumers with unprecedented beauty experiences and services.
According to Shiseido, the program will focus on "medical aesthetics" technology and "holistic aesthetics" technology when it comes to China for the first time this year. The "medical aesthetic" technology aims to create "high efficiency" beauty solutions that meet the needs of Chinese consumers. The "holistic aesthetics" technology provides them with a holistic beauty solution from the inside out through comprehensive health monitoring and management, combined with Shiseido's own strong research strengths.
After a pre-selection process, several startups were selected. They will work with Shiseido's R&D center to verify the feasibility of their projects by employing prototyping and monitoring tests during the subsequent 100-day challenge period. In the final selection in December, Shiseido will select outstanding startups from multiple dimensions for a new collaboration.
Quality Chinese companies are increasingly receiving attention from international beauty giants. Just early last month, Shiseido China announced that its beauty innovation fund "Ziyue Fund" had completed the relevant regulatory filing. Its first investment of nearly 100 million yuan led to a Series A round of financing for recombinant collagen material company Jiangsu Trautec Medical Technology Co.
Shiseido said that the investment aims to arrange new biomaterials for beauty in advance. In the future, it will combine the advantages of product development, raw material supply, and channel resources of both sides to explore the cooperation space of efficacy skincare products. At the same time, it will also help Trautec to further consolidate its leading edge.
Comments